Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-3-23
pubmed:abstractText
Breast cancer resistance protein is a member of the ATP-binding cassette transporter G family that extrudes xenotoxins from cells, mediating drug resistance, and has been recognized as a major cause of failure of various carcinoma chemotherapies. In this study, the modulatory effects of dexamethasone and indomethacin on the cell cytotoxicity of mitoxantrone and on the BCRP protein activity in breast cancer cell lines were examined. MCF cells were seeded at 1 x 10(4) cells per well in 96-well flat-bottomed microplates for 48 hours and treated with increasing doses of dexamethasone, indomethacin, and novobiocin alone or preincubated with increasing doses of the drugs and then coexposed to mitoxantrone. Cell viability was measured after 1-4 days, using the MTT assay. BCRP activity was determined flow cytometrically by measuring mitoxantrone accumulation in the absence and presence of the inhibitor, novobiocin. Cotreatment of mitoxantrone with different concentrations of dexamethasone and indomethacin sensitized parental and resistant MCF-7 cells to mitoxantrone cytotoxicity. Dexamethasone increased the accumulation of mitoxantrone in the MCF-7/MX cell line, indicating an inhibition of BCRP. In spite of increased levels of mitoxantrone cytotoxicity in the presence of indomethacin, the accumulation of mitoxantrone was not increased in indomethacin-treated MCF cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1525-6014
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
113-9
pubmed:meshHeading
pubmed-meshheading:20307139-ATP-Binding Cassette Transporters, pubmed-meshheading:20307139-Antineoplastic Agents, pubmed-meshheading:20307139-Breast Neoplasms, pubmed-meshheading:20307139-Cell Line, Tumor, pubmed-meshheading:20307139-Cell Proliferation, pubmed-meshheading:20307139-Cell Survival, pubmed-meshheading:20307139-Dexamethasone, pubmed-meshheading:20307139-Dose-Response Relationship, Drug, pubmed-meshheading:20307139-Drug Interactions, pubmed-meshheading:20307139-Drug Resistance, Multiple, pubmed-meshheading:20307139-Drug Resistance, Neoplasm, pubmed-meshheading:20307139-Drug Screening Assays, Antitumor, pubmed-meshheading:20307139-Drug Therapy, Combination, pubmed-meshheading:20307139-Female, pubmed-meshheading:20307139-Humans, pubmed-meshheading:20307139-Indomethacin, pubmed-meshheading:20307139-Mitoxantrone, pubmed-meshheading:20307139-Neoplasm Proteins, pubmed-meshheading:20307139-Novobiocin
pubmed:year
2010
pubmed:articleTitle
Evaluation of indomethacin and dexamethasone effects on BCRP-mediated drug resistance in MCF-7 parental and resistant cell lines.
pubmed:affiliation
Biotechnology Laboratory, Biotechnology Research Centre, Bu-Ali Research Institute, Mashhad, Iran.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't